Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Titlesort ascending Journal

Alberto Martini, John Pfail, Francesco Montorsi, Matthew D. Galsky, William K. Oh 

 April 2020 Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial Prostate Cancer and Prostatic Diseases

Omar Abdel-Rahman

 December 2018 Statin Treatment and Outcomes of Metastatic Pancreatic Cancer: A Pooled Analysis of Two Phase III Studies Clinical and Translational Oncology

Jiawei Zhou, Quefeng Li, Yanguang Cao

 February 2021 Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer Cancer Research

Monica M. Bertagnolli, Oliver Sartor, Bruce A. Chabner, Mace L. Rothenberg, Sean Khozin, Charles Hugh-Jones, David M. Reese, Martin J. Murphy

 March 2017 Sounding Board: Advantages of a Truly Open-Access Data-Sharing Model New England Journal of Medicine

Mustafa Hashmi , Jeremy Rassen  & Sebastian Schneeweiss

 June 2021 Single-arm oncology trials and the nature of external controls arms Journal of Comparative Effectiveness Research

Takuma Oda, Shih-Wei Chiu, Takuhiro Yamaguchi

 July 2021 Semi-automated Conversion of Clinical Trial Legacy Data into CDISC SDTM Standards Format Using Supervised Machine Learning Methods of Information in Medicine

Paul Germonpré, Tim Van den Wyngaert and Conteporary Clinical Trials authors are: Louis Dron, Shirin Golchi, Grace Hsu, Kristian Thorlund

 April 2019 Second-Line Erlotinib After Failure of Pemetrexed-Containing Chemotherapy in Advanced non-Small Cell Lung Cancer (NSCLC): Real-World Effectiveness, Safety and Tolerability PLOS ONE

Hirotaka Miyashita, Christina Cruz, Vaibhav Patel 

 August 2021 Risk factors of skeletal-related events in patients with bone metastatic castration-resistant prostate cancer undergoing treatment with zoledronate Supportive Care in Cancer

Hirotaka Miyashita, Christina Cruz, Cardinale Smith

 August 2020 Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate—a post hoc analysis of a randomized clinical trial Supportive Care in Cancer

Hirotaka Miyashita, Christina Cruz, Stephen Malamud

 May 2020 Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate Breast Cancer Research and Treatment

Wei-xiang Qi, Shengguang Zhao, and Jiayi Chen

 October 2019 Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment Future Oncology

Hitesh B. Mistry, Gabriel Helmlinger, Nidal Al-Huniti, Karthick Vishwanathan, James Yates

 April 2019 Resistance Models to EGFR Inhibition and Chemotherapy in Non-Small Cell Lung Cancer Via Analysis of Tumour Size Dynamics Cancer Chemotherapy and Pharmacology

Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller

 September 2020 Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Case Reports in Oncological Medicine

Theresa Wizemann, Eeshan Khandekar, Jennifer Hinners, Carolyn Shore

 July 2020 Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop (2020) National Academies Press

Pages